Your institution may have access to this item. Find your institution then sign in to continue.
Title
Commentary regarding clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study.
A letter to the editor is presented in response to the article "Clinical and immunological outcomes of high-and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study" by A. J. Kanwar and colleagues that is published in the previous issue.